• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MEDTRONIC NEUROSURGERY STRATA II VALVE, REGULAR; SHUNT, CENTRAL NERVOUS SYSTEM AND COMPONENTS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MEDTRONIC NEUROSURGERY STRATA II VALVE, REGULAR; SHUNT, CENTRAL NERVOUS SYSTEM AND COMPONENTS Back to Search Results
Model Number 42866
Medical Device Problem Code Adverse Event Without Identified Device or Use Problem (2993)
Health Effect - Clinical Code Fever (1858)
Date of Event 04/07/2019
Type of Reportable Event Serious Injury
Additional Manufacturer Narrative
If information is provided in the future, a supplemental report will be issued.
 
Event or Problem Description
Information was received regarding a patient undergoing cerebral peritoneal shunt surgery due to traumatic brain injury.It was reported that the patient had a continuous fever that occurred one week after surgery and did not improve.As there was a risk of infection, the device was removed.After the patient returned to normal another surgery was completed.There was no product damage.There were no related patient symptoms.Additional information received reported that no adjustment was done anytime after implantation.No activities/analyses were done on the valve after the removal from the patient prior to sending it to the manufacturer.The valve was not bathed in any chemicals or antibiotics prior to implantation.No mri's were performed while the device was implanted.
 
Additional Manufacturer Narrative
The returned valve was patent.It met the requirements for valve flux, reflux and siphon testing.The catheter from (b)(4) was connected to the valve with a suture.The valve did not meet the requirements for leak testing due to a tear in the reservoir.It is unknown how or when this damage occurred.The instruction for use cautions, ¿improper use of instruments in the handling or implantation of shunt products may result in the cutting, slitting or crushing of components.Such damage may lead to loss of shunt integrity¿¿ the valve did not meet the requirements for pressure flow and preimplantation testing due to proteinaceous debris on the interior of the valve.Proteinaceous debris was also observed on the exterior of the valve.The instructions for use cautions, ¿shunt obstruction may occur in any of the components of the shunt system.The system may become occluded internally due to tissue fragments, blood clots, tumor cell aggregates, bacterial colonization or other debris.¿ all valves are 100% tested at the time of manufacture.If information is provided in the future, a supplemental report will be issued.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
STRATA II VALVE, REGULAR
Common Device Name
SHUNT, CENTRAL NERVOUS SYSTEM AND COMPONENTS
Manufacturer (Section D)
MEDTRONIC NEUROSURGERY
125 cremona drive
goleta CA 93117
MDR Report Key8562406
Report Number2021898-2019-00166
Device Sequence Number11147436
Product Code JXG
UDI-Device Identifier00613994804648
UDI-Public00613994804648
Combination Product (Y/N)N
Initial Reporter CountryCH
PMA/510(K) Number
K042465
Number of Events Summarized1
Summary Report (Y/N)N
Reporter Type Manufacturer
Report Source foreign,health professional
Initial Reporter Occupation Physician
Type of Report Initial,Followup
Report Date (Section B) 06/28/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Operator of Device Health Professional
Device Expiration Date10/31/2019
Device Model Number42866
Device Catalogue Number42866
Device Lot NumberE19352
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer05/08/2019
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 04/08/2019
Supplement Date Received by Manufacturer06/21/2019
Initial Report FDA Received Date04/29/2019
Supplement Report FDA Received Date06/28/2019
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Patient Sequence Number1
Outcome Attributed to Adverse Event Hospitalization; Required Intervention;
-
-